RevCycleAI Brief
Published researchPrior Authorization · AI Medication Access & Prior Authorization · Series C
✦ Ask RevCycleAI about Forus
Pro AI analystGo deeper on competitors, positioning, buyers, funding and market signals.
Unlock Ask RevCycleAI →RevCycleAI Intelligence Scores
Methodology12
2
2
0
Market Matrix: Emerging · Impact 5 · Capability 2
Funding & transaction history
1 trackedSep 8, 2026 · Funding · $150M
Buyer / investor: Lead: Bain Capital Ventures; Also: Thrive Capital, General Catalyst, Accel, Redpoint, BoxGroup, Pear VC, Vast Ventures, SV Angel